Ludwigshafen, Germany

Liliane Unger

USPTO Granted Patents = 125 

 

 

Average Co-Inventor Count = 6.3

ph-index = 12

Forward Citations = 511(Granted Patents)


Inventors with similar research interests:


Location History:

  • Wiesbaden, CH (2016)
  • Wiesbaden, DE (2016 - 2017)
  • Ludwigshafen, DE (1988 - 2018)

Company Filing History:


Years Active: 1988-2018

Loading Chart...
Loading Chart...
Loading Chart...
125 patents (USPTO):

Title: Liliane Unger: Pioneering Innovations in Ludwigshafen

Introduction:

Liliane Unger, an esteemed inventor based in Ludwigshafen, Germany, has made significant contributions to the field of pharmaceuticals. With an extensive portfolio of 123 patents and a strong background in research and development, Unger's work has shaped the landscape of medical treatments. Let's delve deeper into his latest patents, career highlights, collaborations, and more.

Latest Patents:

Unger's latest patents showcase his expertise in developing novel compounds for pharmaceutical applications. One notable invention revolves around the discovery of quinoline compounds. These compounds, as described in the patent, act as modulators of the 5-HT receptor. They hold promise for the prevention and treatment of various conditions and disorders influenced by the modulation of this receptor.

Another recent patent by Unger highlights his groundbreaking work on substituted oxindole derivatives. These compounds, carrying an oxetane substituent, exhibit potential for the treatment of vasopressin-related diseases. The patent describes their pharmaceutical composition and outlines their specific use for addressing vasopressin-related disorders.

Career Highlights:

Throughout his career, Unger has been associated with leading pharmaceutical companies, including Abbott GmbH & Co. KG and BASF Aktiengesellschaft. His impactful contributions in these renowned organizations have propelled advancements in drug development and therapeutic interventions.

Collaborations:

Unger's collaborations with exceptional researchers, such as Wolfgang Wernet and Andreas Haupt, have greatly influenced the outcome of his projects. These collaborations have fostered an environment of knowledge exchange and teamwork, enabling Unger to leverage diverse perspectives and expertise for the success of his inventions.

Conclusion:

Liliane Unger's prolific career and dedication to innovation have positioned him as a vital figure in the pharmaceutical industry. His extensive patent portfolio, including the recent groundbreaking discoveries in quinoline compounds and substituted oxindole derivatives, underscores his commitment to advancing medical treatments. By collaborating with esteemed professionals and contributing to renowned companies, Unger has left an indelible mark on the field of pharmaceutical research and development.

Disclaimer: The above information is based on the provided data and is subject to the availability of accurate records.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…